NOVN — Novartis AG Cashflow Statement
0.000.00%
- CH₣174.58bn
- CH₣189.47bn
- $51.72bn
- 97
- 32
- 85
- 87
Annual cashflow statement for Novartis AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 8,071 | 24,018 | 6,955 | 8,572 | 11,939 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 3,842 | -11,714 | 4,404 | 2,403 | 5,517 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4,727 | -3,346 | -4,304 | -4,794 | -4,436 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 13,650 | 15,071 | 14,236 | 14,458 | 17,619 |
Capital Expenditures | -2,585 | -2,971 | -2,671 | -2,753 | -3,814 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -10,597 | 7,179 | 4,139 | 8,349 | -3,699 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -13,182 | 4,208 | 1,468 | 5,596 | -7,513 |
Financing Cash Flow Items | -199 | 94 | 55 | 3,478 | -207 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2,208 | -16,264 | -20,562 | -14,278 | -11,742 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,454 | 2,749 | -4,890 | 5,876 | -1,934 |